ALLMedicine™ Liver Transplants Center

Feb 27th, 2021 - Allogeneic liver transplants tolerize the immune system, preventing organ rejection from the same donor. A recent article by Yu et al. shows that liver metastases can likewise prevent tumor rejection in immunotherapy-treated murine and human hosts...

Feb 23rd, 2021 - Enhanced recovery after surgery (ERAS) has been shown to facilitate discharge, decrease length of stay, improve outcomes and reduce costs. We used this concept to design a comprehensive fast-track pathway (OR-to-discharge) before starting our live...

Feb 19th, 2021 - Early acute rejection (EAR) is a common complication after liver transplantation (LT). The aim of this study was to evaluate the incidence and risk factors of EAR in donation after cardiac death (DCD) liver transplantation recipients. We retrospec...

Feb 17th, 2021 - This year was notable for changes to exception points determined by the geographic median allocation Model for End-Stage Liver Disease (MELD) and implementation of the National Liver Review Board, which took place on May 14, 2019. The national acu...

Feb 17th, 2021 - To review the impact of delayed kidney transplantation approach in combined (simultaneous) liver-kidney transplantation (CLKT). CLKT offers a life-saving procedure for patients with both end-stage liver disease and chronic kidney disease or prolon...

Dec 31st, 2012 - Liver disease is the twelfth commonest cause of mortality in adults in the United States, resulting in 34,000 deaths annually from cirrhosis. 7 In addition, the rising incidence of HCC in the United States is reflected in an increasing number of de.

Feb 27th, 2021 - Allogeneic liver transplants tolerize the immune system, preventing organ rejection from the same donor. A recent article by Yu et al. shows that liver metastases can likewise prevent tumor rejection in immunotherapy-treated murine and human hosts...

Feb 23rd, 2021 - Enhanced recovery after surgery (ERAS) has been shown to facilitate discharge, decrease length of stay, improve outcomes and reduce costs. We used this concept to design a comprehensive fast-track pathway (OR-to-discharge) before starting our live...

Feb 19th, 2021 - Early acute rejection (EAR) is a common complication after liver transplantation (LT). The aim of this study was to evaluate the incidence and risk factors of EAR in donation after cardiac death (DCD) liver transplantation recipients. We retrospec...

Feb 17th, 2021 - This year was notable for changes to exception points determined by the geographic median allocation Model for End-Stage Liver Disease (MELD) and implementation of the National Liver Review Board, which took place on May 14, 2019. The national acu...

Feb 17th, 2021 - To review the impact of delayed kidney transplantation approach in combined (simultaneous) liver-kidney transplantation (CLKT). CLKT offers a life-saving procedure for patients with both end-stage liver disease and chronic kidney disease or prolon...

Aug 19th, 2020 - NEW YORK (Reuters Health) - Most patients will develop liver fibrosis after their Fontan procedure, and many will require heart-liver transplants, according to a new review. "Fontan-associated liver disease (FALD) is underdiagnosed," Dr. Juliet Em...

May 11th, 2020 - NEW YORK (Reuters Health) - The COVID-19 pandemic has led to a sharp drop in organ transplantation in the United States and France, a new report in The Lancet shows. From late February to early April, deceased donor transplantations fell by 51.1% ...

Apr 1st, 2020 - In liver transplant recipients or patients with autoimmune hepatitis on immunosuppressive therapy, acute cellular rejection or disease flare should not be presumed in the face of active coronavirus disease 2019 (COVID-19), according to the America.

Dec 16th, 2019 - (Reuters) - Gilead Sciences Inc said on Monday all combinations of its three drugs to treat NASH were unsuccessful in a mid-stage study, the latest failure in a string of trials seeking to develop the first approved treatment for the fatty liver d...

Nov 6th, 2019 - Liver transplant for the three predominant autoimmune liver diseases – primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis – has been known to have favorable outcomes overall, but little evidence comparing cholang.